# Electrochemoterapy With Bleomycin for the Treatment of Unresectable Pancreatic Cancer

> **NCT03225781** · NA · TERMINATED · sponsor: **Universita di Verona** · enrollment: 1 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DEVICE:** Electrochemotherapy with Bleomycin

## Key facts

- **NCT ID:** NCT03225781
- **Lead sponsor:** Universita di Verona
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-07-01
- **Primary completion:** 2018-12-21
- **Final completion:** 2018-12-21
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Logistic reasons
- **Last updated:** 2018-12-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03225781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03225781, "Electrochemoterapy With Bleomycin for the Treatment of Unresectable Pancreatic Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03225781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*